Retinoic acid in hepatocytes and PAPRγ-mediated CB1R activation promote lipogenesis and inhibit fatty acid oxidation in the liver, thereby aggravating hepatic steatosis. The gene discussed is CNR1; the disease is Hepatic steatosis.